Literature DB >> 29500670

Role of G protein-regulated inducer of neurite outgrowth 3 (GRIN3) in β-arrestin 2-Akt signaling and dopaminergic behaviors.

Yasumasa Mototani1, Tadashi Okamura2, Motohito Goto2, Yukiko Shimizu2, Rieko Yanobu-Takanashi2, Aiko Ito1,3, Naoya Kawamura1,4, Yuka Yagisawa1,3, Daisuke Umeki1,3, Megumi Nariyama1,5, Kenji Suita1, Yoshiki Ohnuki1, Kouichi Shiozawa1, Yoshinori Sahara6, Tohru Kozasa7, Yasutake Saeki1, Satoshi Okumura8.   

Abstract

The G protein-regulated inducer of neurite growth (GRIN) family has three isoforms (GRIN1-3), which bind to the Gαi/o subfamily of G protein that mediate signal processing via G protein-coupled receptors (GPCRs). Here, we show that GRIN3 is involved in regulation of dopamine-dependent behaviors and is essential for activation of the dopamine receptors (DAR)-β-arrestin signaling cascade. Analysis of functional regions of GRIN3 showed that a di-cysteine motif (Cys751/752) is required for plasma membrane localization. GRIN3 was co-immunoprecipitated with GPCR kinases 2/6 and β-arrestins 1/2. Among GRINs, only GRIN3, which is highly expressed in striatum, strongly interacted with β-arrestin 2. We also generated GRIN3-knockout mice (GRIN3KO). GRIN3KO exhibited reduced locomotor activity and increased anxiety-like behavior in the elevated maze test, as well as a reduced locomoter response to dopamine stimulation. We also examined the phosphorylation of Akt at threonine 308 (phospho308-Akt), which is dephosphorylated via a β-arrestin 2-mediated pathway. Dephosphorylation of phospho308-Akt via the D2R-β-arrestin 2 signaling pathway was completely abolished in striatum of GRIN3KO. Our results suggest that GRIN3 has a role in recruitment and assembly of proteins involved in β-arrestin-dependent, G protein-independent signaling.

Entities:  

Keywords:  Akt; Dopamine receptor; GRIN3; GRIN3-knockout mice; β-Arrestin

Mesh:

Substances:

Year:  2018        PMID: 29500670     DOI: 10.1007/s00424-018-2124-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  25 in total

1.  A candidate target for G protein action in brain.

Authors:  L T Chen; A G Gilman; T Kozasa
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

2.  Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Authors:  Raul R Gainetdinov; Laura M Bohn; Tatyana D Sotnikova; Michel Cyr; Aki Laakso; Alexander D Macrae; Gonzalo E Torres; Kyeong Man Kim; Robert J Lefkowitz; Marc G Caron; Richard T Premont
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

Review 3.  Mammalian G proteins and their cell type specific functions.

Authors:  Nina Wettschureck; Stefan Offermanns
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

4.  Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain.

Authors:  M Erdtmann-Vourliotis; P Mayer; S Ammon; U Riechert; V Höllt
Journal:  Brain Res Mol Brain Res       Date:  2001-11-01

Review 5.  Regulation of G proteins by covalent modification.

Authors:  C A Chen; D R Manning
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

6.  Motor dysfunction in type 5 adenylyl cyclase-null mice.

Authors:  Tamio Iwamoto; Satoshi Okumura; Kousaku Iwatsubo; Jun-Ichi Kawabe; Koji Ohtsu; Ikuko Sakai; Yoko Hashimoto; Aki Izumitani; Kazunori Sango; Kyoko Ajiki; Yoshiyuki Toya; Satoshi Umemura; Yoshio Goshima; Nobutaka Arai; Stephen F Vatner; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

7.  Functional characterization of Galphao signaling through G protein-regulated inducer of neurite outgrowth 1.

Authors:  Hiroko Nakata; Tohru Kozasa
Journal:  Mol Pharmacol       Date:  2004-12-07       Impact factor: 4.436

Review 8.  The physiology, signaling, and pharmacology of dopamine receptors.

Authors:  Jean-Martin Beaulieu; Raul R Gainetdinov
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 9.  New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.

Authors:  Satoshi Okumura; Sayaka Suzuki; Yoshihiro Ishikawa
Journal:  J Pharmacol Sci       Date:  2009-03-07       Impact factor: 3.337

10.  G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation.

Authors:  Yoon Namkung; Concetta Dipace; Eneko Urizar; Jonathan A Javitch; David R Sibley
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

View more
  4 in total

1.  GPRIN3 Controls Neuronal Excitability, Morphology, and Striatal-Dependent Behaviors in the Indirect Pathway of the Striatum.

Authors:  Deniz Karadurmus; Daniel Rial; Jean-François De Backer; David Communi; Alban de Kerchove d'Exaerde; Serge N Schiffmann
Journal:  J Neurosci       Date:  2019-07-30       Impact factor: 6.167

2.  Gene expression correlates of advanced epigenetic age and psychopathology in postmortem cortical tissue.

Authors:  Erika J Wolf; Xiang Zhao; Sage E Hawn; Filomene G Morrison; Zhenwei Zhou; Dana Fein-Schaffer; Bertrand Huber; Mark W Miller; Mark W Logue
Journal:  Neurobiol Stress       Date:  2021-07-29

3.  Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice.

Authors:  Yuka Yagisawa; Kenji Suita; Yoshiki Ohnuki; Misao Ishikawa; Yasumasa Mototani; Aiko Ito; Ichiro Matsuo; Yoshio Hayakawa; Megumi Nariyama; Daisuke Umeki; Yasutake Saeki; Yasuharu Amitani; Yoshiki Nakamura; Hiroshi Tomonari; Satoshi Okumura
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

4.  β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression.

Authors:  Xiu-Qin Li; Wen-Ting Peng; Shan Shan; Jing-Jing Wu; Nan Li; Jia-Jia Du; Jia-Chang Sun; Ting-Ting Chen; Wei Wei; Wu-Yi Sun
Journal:  J Cancer       Date:  2021-10-28       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.